NFSG
GCTK icon

Newbridge Financial Services Group’s GlucoTrack GCTK Stock Holding History

Newbridge Financial Services Group’s Portfolio GCTK Stock Details GCTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22 Hold
34
– – ﹤0.01% 1169
2025
Q4 		$132 Hold
34
– – ﹤0.01% 1145
2025
Q3 		$224 Hold
34
– – ﹤0.01% 1245
2025
Q2 		$204 Buy
+34
New +$299 ﹤0.01% 1265

Other funds holding GCTK

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
AF
Alerus Financial Grand Forks, North Dakota $2.02B AUM 26.03% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Newbridge Financial Services Group's GCTK Position: Q1 2026 in Review

Newbridge Financial Services Group held its GlucoTrack (GCTK) position steady in Q1 2026 at 34 shares worth $22. The position accounts for ﹤0.01% of the portfolio, ranked #1169.

Newbridge Financial Services Group first reported a position in GCTK in Q2 2025 and has held it in 4 quarters since. The position peaked at $224 in Q3 2025. 13 funds tracked by Wall St. Rank hold GCTK as of Q1 2026.

  • Newbridge Financial Services Group held 34 shares of GlucoTrack worth $22 as of Q1 2026.
  • Newbridge Financial Services Group left its GlucoTrack share count unchanged in Q1 2026.
  • GlucoTrack made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q1 2026, its #1169 holding.
  • Newbridge Financial Services Group first reported a position in GlucoTrack in Q2 2025 and has held it in 4 quarters since.
  • Newbridge Financial Services Group's GlucoTrack position peaked at $224 in Q3 2025.
  • 13 funds tracked by Wall St. Rank held GlucoTrack as of Q1 2026.

Based on Newbridge Financial Services Group's 13F filing for Q1 2026, filed 5 May 2026.